Abstract | BACKGROUND: METHODS AND RESULTS: We included 15 patients with TNA, 69 with TIA accompanied by nonfocal symptoms, 58 with large-vessel TIA, 32 with cardioembolic TIA, and 46 age- and sex-matched healthy control participants. Serum NT-proBNP levels were determined within 1 week after the attack. We compared log-transformed NT-proBNP levels of patients with cardioembolic TIAs and mixed or nonfocal TNAs, with those of patients with noncardioembolic TIAs as a reference group. Adjustments for age, sex, atrial fibrillation, and a history of nonischemic heart disease were made with a multiple linear regression model. Compared with large-vessel TIA (mean 14.2 pmol/L), mean NT-proBNP levels were significantly higher in patients with TIA accompanied by nonfocal symptoms (40.5 pmol/L, P=0.049) and with cardioembolic TIA (123.5 pmol/L; P=0.004) after adjustments for age, sex, atrial fibrillation, and a history of nonischemic heart disease. Patients with TNA also had higher mean NT-proBNP levels (20.8 pmol/L, P=0.38) than those with large-vessel TIA, but this difference was not statistically significant. CONCLUSION:
NT-proBNP levels are increased in patients with TIA accompanied by nonfocal symptoms.
|
Authors | Gerben J J Plas, Susanne D Jurg, Marjolein Brusse-Keizer, Diederik W J Dippel, Peter J Koudstaal, Heleen M den Hertog |
Journal | Journal of the American Heart Association
(J Am Heart Assoc)
Vol. 4
Issue 12
(Dec 15 2015)
ISSN: 2047-9980 [Electronic] England |
PMID | 26672079
(Publication Type: Journal Article)
|
Copyright | © 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. |
Chemical References |
- Biomarkers
- Peptide Fragments
- pro-brain natriuretic peptide (1-76)
- Natriuretic Peptide, Brain
|
Topics |
- Biomarkers
(blood)
- Case-Control Studies
- Confusion
(blood, etiology)
- Dizziness
(blood, etiology)
- Female
- Humans
- Ischemic Attack, Transient
(blood, complications, pathology)
- Male
- Middle Aged
- Natriuretic Peptide, Brain
(blood)
- Paresthesia
(blood, etiology)
- Peptide Fragments
(blood)
- Vision Disorders
(blood, etiology)
|